ConductScience.org, home

Paper41357313

SCOPING: A Multidisciplinary Treatment Protocol for Neovascular Glaucoma with Completely Open or Partially Open Angles.

Mokhashi N and 7 others. Clin Ophthalmol, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. SCOPING: A Multidisciplinary Treatment Protocol for Neovascular Glaucoma with Completely Open or Partially Open Angles. Papers, record 41357313. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41357313

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
SCOPING: A Multidisciplinary Treatment Protocol for Neovascular Glaucoma with Completely Open or Partially Open Angles.
PubMed
Journal
Clin Ophthalmol
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-09-19
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mokhashi NNikitahttps://orcid.org/0000-0001-9510-3747
2Kanter JJacob
3Komati RRahul
4Mackin AAnna
5Dao DDavid
6Amin PPathik
7Skondra DDimitra
8Qiu MMaryhttps://orcid.org/0000-0002-0062-7386

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123907153Analysis of morphological features and vascular layers of choroid in diabetic retinopathy using spectral-domain optical coherence tomography.JAMA Ophthalmol2013https://conductscience.org/library/papers/23907153PubMed
237929013Cyclophotocoagulation in Neovascular Glaucoma with Near-Total Synechial Angle Closure.Case Rep Ophthalmol Med2023https://conductscience.org/library/papers/37929013PubMed
335935916Neovascular Glaucoma from Ocular Ischemic Syndrome Treated with Serial Monthly Intravitreal Bevacizumab and Panretinal Photocoagulation: A Case Report.Case Rep Ophthalmol Med2022https://conductscience.org/library/papers/35935916PubMed
418440643Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.Ophthalmology2008https://conductscience.org/library/papers/18440643PubMed
530587917Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab.Clin Ophthalmol2019https://conductscience.org/library/papers/30587917PubMed
63692707
Techniques for scatter and local photocoagulation treatment of diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report no. 3. The Early Treatment Diabetic Retinopathy Study Research Group.
Int Ophthalmol Clin1987https://conductscience.org/library/papers/3692707PubMed
735031284Improving Outcomes in Neovascular Glaucoma.Ophthalmol Glaucoma2022https://conductscience.org/library/papers/35031284PubMed
828992424Long-Term Outcome of Intravitreal Bevacizumab Followed by Ahmed Valve Implantation in the Management of Neovascular Glaucoma.Semin Ophthalmol2018https://conductscience.org/library/papers/28992424PubMed
919373696Neovascular glaucoma: etiology, diagnosis and prognosis.Semin Ophthalmol2009https://conductscience.org/library/papers/19373696PubMed
1034487226Gonioscopy-assisted transluminal trabeculotomy for chronic angle-closure glaucoma: preliminary results.Graefes Arch Clin Exp Ophthalmol2022https://conductscience.org/library/papers/34487226PubMed
1119826393Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial.J Glaucoma2009https://conductscience.org/library/papers/19826393PubMed
1236051187Gonioscopy-assisted transluminal trabeculotomy in neovascular glaucoma: Salvaging the conventional outflow pathway.Am J Ophthalmol Case Rep2022https://conductscience.org/library/papers/36051187PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42254353Neovascular glaucoma: pathophysiology, diagnosis, and contemporary management.Front Med (Lausanne)2026https://conductscience.org/library/papers/42254353

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41357313

GET https://conductscience.org/api/papers/v1/41357313/authors